Tag: FDA regulations

Bioequivalence Waivers: When the FDA Skips In-Vivo Studies

Bioequivalence Waivers: When the FDA Skips In-Vivo Studies

Discover when the FDA allows bioequivalence waivers, skipping costly human trials for generic drugs. Learn about BCS Class I and III eligibility, dissolution testing requirements, and the financial benefits of biowaivers.

False Advertising in Generics: Legal Risks and Rules You Can't Ignore

False Advertising in Generics: Legal Risks and Rules You Can't Ignore

False advertising in generic drugs misleads patients, harms competition, and violates federal law. Learn the legal risks, FDA rules, and what claims are allowed-or banned-in 2025.

Latest Posts

Categories

Tags Cloud